Neuroquímida y Neurodegeneración
Hospital Universitario de Donostia
San Sebastián, EspañaPublications in collaboration with researchers from Hospital Universitario de Donostia (9)
2022
-
Development of castration resistance in prostate cancer patients treated with luteinizing hormone-releasing hormone analogues (LHRHa): results of the ANARESISTANCE study
World Journal of Urology, Vol. 40, Núm. 10, pp. 2459-2466
2021
-
Finding genetically-supported drug targets for Parkinson’s disease using Mendelian randomization of the druggable genome
Nature Communications, Vol. 12, Núm. 1
-
Human-lineage-specific genomic elements are associated with neurodegenerative disease and APOE transcript usage
Nature Communications, Vol. 12, Núm. 1
2019
-
SNCA and mTOR Pathway Single Nucleotide Polymorphisms Interact to Modulate the Age at Onset of Parkinson's Disease
Movement Disorders, Vol. 34, Núm. 9, pp. 1333-1344
-
The Genetic Architecture of Parkinson Disease in Spain: Characterizing Population-Specific Risk, Differential Haplotype Structures, and Providing Etiologic Insight
Movement Disorders, Vol. 34, Núm. 12, pp. 1851-1863
2017
-
A protective personal factor against disability and dependence in the elderly: an ordinal regression analysis with nine geographically-defined samples from Spain
BMC Geriatrics, Vol. 17, Núm. 1, pp. 1-10
2016
-
Dysexecutive syndrome in amnesic mild cognitive impairment: A multicenter study
BMC Neurology, Vol. 16, Núm. 1
2015
-
Autonomic involvement in Parkinsonian carriers of PARK2 gene mutations
Parkinsonism and Related Disorders, Vol. 21, Núm. 7, pp. 717-722